Naotoshi Sugimoto Selected Research

1-palmitoylphosphatidylethanolamine

1/2009

Inhibitory effect of N-palmitoylphosphatidylethanolamine on macrophage phagocytosis through inhibition of Rac1 and Cdc42.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Naotoshi Sugimoto Research Topics

Disease

27	Neoplasms (Cancer) 08/2022 - 06/2002
26	Stomach Neoplasms (Stomach Cancer) 10/2021 - 11/2004
18	Colorectal Neoplasms (Colorectal Cancer) 04/2021 - 10/2012
10	Osteosarcoma (Osteogenic Sarcoma) 01/2017 - 10/2009
8	Inflammation (Inflammations) 08/2019 - 06/2002
8	Neutropenia 01/2017 - 01/2008
8	Neoplasm Metastasis (Metastasis) 01/2017 - 10/2009
7	Adenocarcinoma 08/2022 - 10/2012
5	Hemolytic-Uremic Syndrome 12/2021 - 09/2016
5	Glioblastoma (Glioblastoma Multiforme) 08/2019 - 05/2010
4	Anemia 03/2020 - 12/2013
4	Glioma (Gliomas) 01/2014 - 05/2010
3	Body Weight (Weight, Body) 05/2022 - 05/2019
3	Disease Progression 10/2021 - 10/2014
3	Fatigue 12/2018 - 10/2014
3	Hypoxia (Hypoxemia) 12/2017 - 06/2011
3	Hypothermia 12/2011 - 10/2004
2	Hemorrhage 04/2021 - 01/2017
2	Colonic Neoplasms (Colon Cancer) 01/2021 - 01/2018
2	Infections 01/2020 - 09/2016
2	Breast Neoplasms (Breast Cancer) 03/2019 - 01/2017
2	Anorexia 12/2018 - 12/2013
2	Hyponatremia 12/2018 - 07/2016
2	Brain Neoplasms (Brain Tumor) 12/2017 - 03/2013
2	Brain Diseases (Brain Disorder) 12/2017 - 09/2016
2	Embolism (Embolus) 01/2017 - 08/2016
2	Fibrosis (Cirrhosis) 01/2017 - 02/2010
2	Fever (Fevers) 10/2013 - 08/2003
2	Esophageal Neoplasms (Esophageal Cancer) 06/2012 - 01/2010
2	Atherosclerosis 11/2010 - 03/2004
1	Meningeal Carcinomatosis 10/2022
1	Lung Neoplasms (Lung Cancer) 10/2022
1	Meningitis 10/2022
1	Hypertrophy 05/2022
1	Atrophy 05/2022

Drug/Important Bio-Agent (IBA)

14	Irinotecan (Camptosar)FDA LinkGeneric 10/2021 - 11/2004
12	Oxaliplatin (Eloxatin)FDA LinkGeneric 08/2022 - 10/2012
10	Cisplatin (Platino)FDA LinkGeneric 08/2022 - 12/2013
10	S-1 plus cisplatinIBA 10/2021 - 01/2016
8	Paclitaxel (Taxol)FDA LinkGeneric 10/2021 - 01/2008
8	trifluridine tipiracil drug combinationIBA 04/2021 - 10/2012
7	Proteins (Proteins, Gene)FDA Link 05/2022 - 05/2010
7	IntegrinsIBA 01/2017 - 08/2013
6	Biomarkers (Surrogate Marker)IBA 12/2021 - 04/2015
6	regorafenibIBA 04/2021 - 01/2018
6	Green Fluorescent ProteinsIBA 01/2017 - 08/2013
5	Bevacizumab (Avastin)FDA Link 08/2020 - 11/2015
4	Capecitabine (Xeloda)FDA Link 09/2020 - 02/2015
4	PlatinumIBA 01/2019 - 12/2013
3	TheobromineIBA 05/2022 - 01/2014
3	RamucirumabIBA 01/2021 - 10/2014
3	Fluorouracil (Carac)FDA LinkGeneric 11/2019 - 01/2016
3	CannabinoidsIBA 08/2019 - 10/2012
3	Caffeine (No Doz)FDA LinkGeneric 11/2013 - 08/2011
3	sphingosine 1-phosphate (sphingosine-1-phosphate)IBA 11/2010 - 08/2003
3	Sphingosine-1-Phosphate ReceptorsIBA 11/2010 - 02/2010
2	Adenosine Monophosphate (AMP)IBA 05/2022 - 03/2013
2	EnzymesIBA 05/2022 - 12/2017
2	PlasticsIBA 05/2022 - 08/2014
2	LipidsIBA 05/2022 - 01/2009
2	Indicators and Reagents (Reagents)IBA 12/2021 - 12/2017
2	NivolumabIBA 02/2021 - 01/2019
2	Pharmaceutical PreparationsIBA 01/2020 - 03/2019
2	Trastuzumab (Herceptin)FDA Link 01/2020 - 01/2018
2	afliberceptIBA 11/2019 - 03/2019
2	Cannabinoid Receptors (Cannabinoid Receptor)IBA 08/2019 - 10/2012
2	EndocannabinoidsIBA 08/2019 - 12/2017
2	Interleukin-33IBA 04/2019 - 05/2013
2	InterleukinsIBA 04/2019 - 05/2013
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 12/2017 - 05/2010
2	Cyclooxygenase 2 (Cyclooxygenase-2)IBA 12/2017 - 10/2013
2	CollagenIBA 01/2017 - 08/2013
2	Leucovorin (Folinic Acid)FDA Link 01/2017 - 01/2016
2	DisintegrinsIBA 12/2016 - 01/2016
2	echistatinIBA 12/2016 - 01/2016
2	XELOXIBA 11/2015 - 02/2015
2	Type 4 Cyclic Nucleotide PhosphodiesterasesIBA 01/2014 - 03/2013
2	TOR Serine-Threonine KinasesIBA 01/2014 - 09/2012
2	Mitogen-Activated Protein KinasesIBA 03/2013 - 09/2012
2	Small Interfering RNA (siRNA)IBA 08/2011 - 05/2010
2	LysophospholipidsIBA 06/2006 - 06/2002
2	Taxoids (Taxanes)IBA 06/2006 - 11/2004
1	dacomitinibIBA 10/2022
1	AfatinibIBA 10/2022
1	pembrolizumabIBA 08/2022
1	human ERBB2 proteinIBA 08/2022
1	B7-H1 AntigenIBA 08/2022
1	ClenbuterolIBA 05/2022
1	Shiga Toxin 2IBA 12/2021
1	Insulin-Like Growth Factor Binding ProteinsIBA 12/2021
1	Insulin-Like Growth Factor Binding Protein 2IBA 12/2021
1	LipopolysaccharidesIBA 12/2021
1	Tumor Necrosis Factor Receptors (Tumor Necrosis Factor Receptor)IBA 12/2021

Therapy/Procedure

26	Drug Therapy (Chemotherapy) 08/2022 - 11/2004
17	Therapeutics 02/2021 - 03/2009
4	Adjuvant Chemotherapy 10/2021 - 01/2019
3	Combination Drug Therapy (Combination Chemotherapy) 10/2021 - 06/2006
2	Radiotherapy 01/2019 - 01/2012
2	Chemoradiotherapy 06/2012 - 01/2010
2	Injections 05/2010 - 10/2004